Values First Advisors, Inc. Praxis Precision Medicines, Inc. Transaction History

Values First Advisors, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 20, 2022	SELL	$1.75 - $11.34 $80,482 - $521,526	-45,990 Closed	0 $0
Q1 2022 May 03, 2022	BUY	$10.21 - $20.29 $106,377 - $211,401	10,419 Added 29.29%	45,990 $470,000
Q4 2021 Mar 10, 2022	BUY	$16.76 - $22.99 $596,169 - $817,777	35,571 New	35,571 $701,000
Q3 2021 Nov 15, 2022	BUY	$13.15 - $22.56 $348,172 - $597,321	26,477 New	26,477 $490,000

75K

Ticker PRAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,576,100
Market Cap $3.54B
Description
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of ...

Get notified when there are updates to the investment portfolio of Values First Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Values First Advisors, Inc. with notifications on news.